ClinicalTrials.Veeva

Menu
A

AMCR Institute, Inc | Escondido, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3298176
Orforglipron
Insulin aspart
Tirzepatide
Dasiglucagon
Ranolazine
Nasulin
CT-388
mifepristone
LY3841136

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 82 total trials

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-2)

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or o...

Enrolling
Overweight
Type 1 Diabetes
Drug: Placebo
Drug: Tirzepatide

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388...

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM)
Overweight or Obese
Drug: CT-388
Drug: Placebo
New

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants...

Begins enrollment this month
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-rela...

Active, not recruiting
Overweight or Obesity
Overweight
Drug: Placebo
Drug: Orforglipron

The purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with dia...

Not yet enrolling
Type 1 Diabetes
Diabetes Mellitus
Device: RIGHTEST Continuous Glucose Monitoring System
Status recently updated

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or...

Enrolling
Active, not recruiting
Overweight
Obesity
Other: Placebo
Drug: Petrelintide

A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features. The purpose of this clinical investi...

Enrolling
Diabetes Mellitus, Type 1
Diabetes Mellitus
Device: Continuous Glucose Monitoring System

Trial sponsors

Ascensia Diabetes Care logo
Medtronic logo
Lilly logo
Dexcom logo
S
Becton, Dickinson and Company (BD) logo
Corcept Therapeutics logo
Zealand Pharma logo
Abbott logo
Halozyme logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems